Harsch Mutya has filed 14 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 4007 shares of VYNE Therapeutics Inc. ($VYNE) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 4007 | $0.60 | 121,898.0000 | 42,589,000 | 3.18% | 0.01% |
| Dec. 31, 2025 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 3579 | $0.58 | 125,905.0000 | 42,589,000 | 2.76% | 0.01% |
| Sept. 30, 2025 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 3581 | $0.34 | 129,484.0000 | 42,589,000 | 2.69% | 0.01% |
| June 30, 2025 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 3581 | $1.65 | 133,065.0000 | 42,589,000 | 2.62% | 0.01% |
| June 2, 2025 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | A | Common Stock | 1145 | $0.81 | 136,646.0000 | 42,589,000 | 0.85% | 0.00% |
| March 31, 2025 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 8828 | $1.58 | 135,501.0000 | 42,589,000 | 6.12% | 0.02% |
| Jan. 21, 2025 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | A | Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 42,589,000 | 9999.99% | 0.54% |
| Dec. 31, 2024 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 4697 | $3.35 | 144,329.0000 | 10,273,000 | 3.15% | 0.05% |
| Sept. 30, 2024 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 105 | $1.88 | 149,026.0000 | 10,273,000 | 0.07% | 0.00% |
| July 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 143 | $1.92 | 149,131.0000 | 10,273,000 | 0.10% | 0.00% |
| April 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | F | Common Stock | 161 | $3.08 | 149,274.0000 | 10,273,000 | 0.11% | 0.00% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | Chief Legal Officer and GC | A | Common Stock | 62500 | $0.00 | 149,596.0000 | 10,273,000 | 71.76% | 0.61% |
| Jan. 2, 2024 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | Chief Legal Officer and GC | F | Common Stock | 161 | $2.28 | 149,435.0000 | 10,273,000 | 0.11% | 0.00% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Harsch Mutya | Chief Legal Officer and GC | A | Stock Option (right to buy) | 62500 | $0.00 | 62,500.0000 | 10,273,000 | 9999.99% | 0.61% |